In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Chris Kapelios
Speaker
Chris Kapelios
Chris Kapelios Chris Kapelios

Laiko University General Hospital, Athens (Greece)

Specialities : Chronic Heart Failure , Acute Heart Failure, Public Health and Health Economics

Chris J. Kapelios received his MD summa cum laude from the National and Kapodistrian University of Athens in 2010. He went on to complete his Ph.D. on myocardial ischemia-reperfusion injury in 2016. He is currently a cardiology fellow in Laiko General Hospital in Athens, Greece and a senior student in the Executive MSc Health Economics, Outcomes and Management in Cardiovascular Sciences in the London School of Economics. His research interest focuses primarily on heart failure and cardiovascular imaging, topics on which he has published to date more than 45 articles in high-esteemed, peer-reviewed journals.

28 presentations from this speaker

Aortopulmonary fistula complicating native aortic valve endocarditis

Event : EuroEcho 2019

  • Session : Valvular heart disease
  • Speaker : C Kapelios (Athens,GR)

High prevalence of left ventricular systolic dysfunction assessed by speckle tracking in asymptomatic HIV patients

Event : EuroEcho 2019

  • Session : Tissue Doppler, Speckle Tracking and Strain Imaging
  • Speaker : C Kapelios (Athens,GR)

Association between high-dose spironolactone and decongestion in patients with acute heart failure

Event : Heart Failure 2018

  • Session : Acute Heart Failure– Treatment
  • Speaker : C Kapelios (Athens,GR)

High prevalence of left ventricular systolic dysfunction assessed by speckle tracking in asymptomatic patients with diabetes mellitus type 1

Event : Heart Failure 2018

  • Session : Autoimmune/Chronic Inflammatory Disorders and Heart Disease
  • Speaker : C Kapelios (Athens,GR)

Recurrent episodes of life-threatening vasodilatory shock following unintentional intoxication with calcium channel blocker, amlodipine

Event : Heart Failure 2016

  • Session : Clinical Case Corner 3: Catch me, if you can: cases of very fast (or slow) heart - Part II
  • Speaker : C Kapelios (Athens,GR)

Chronic intermittent renal replacement therapy in end-stage heart failure patients: a randomized study- one year results.

Event : Heart Failure 2015

  • Session : Diuretics and fluid status management
  • Speaker : C Kapelios (Athens,GR)

Profound pressure unloading induced by a novel implantable counterpulsation assist device in a porcine model of acute heart failure

Event : Heart Failure 2015

  • Session : Basic Science: Acute and advanced heart failure
  • Speaker : C Kapelios (Athens,GR)

Prognostic factors for exit-site infections in patients with LVADs

Event : Heart Failure 2015

  • Session : Devices / Artificial heart / CRT / ICD
  • Speaker : C Kapelios (Athens,GR)

Quality of life in advanced heart failure is improved by chronic intermittent renal replacement therapy

Event : Heart Failure 2015

  • Session : Diuretics and fluid status management
  • Speaker : C Kapelios (Athens,GR)

Surgical technique and feasibility of implantation of a novel pressure unloading left ventricular assist device (PULVAD)

Event : Heart Failure 2015

  • Session : Devices / Artificial heart / CRT / ICD
  • Speaker : C Kapelios (Athens,GR)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are